Mega Lifesciences PCL
SET:MEGA
Mega Lifesciences PCL
Long-Term Debt
Mega Lifesciences PCL
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Mega Lifesciences PCL
SET:MEGA
|
Long-Term Debt
฿121.9m
|
CAGR 3-Years
8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
B
|
Bangkok Lab and Cosmetic PCL
SET:BLC
|
Long-Term Debt
฿42.5m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Mega Lifesciences PCL
Glance View
Mega Lifesciences Public Co. Ltd. engages in the manufacture, market, sale, and distribution of pharmaceutical, nutraceutical products, and consumer goods. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2013-11-19. The firm's products include complimentary medicines, over-the-counter (OTC) medicines and prescription medicines to both domestic and international markets. The company distributes products under Maxxcare brand covering prescription pharmaceutical products, OTC drugs and other consumer products. The firm also offers nutritional products, prescription pharmaceutical products and OTC drugs under Mega We Care brand. In addition, the Company operates as an original equipment manufacturer (OEM) for various products including health supplements, pharmaceutical, herbal products, vitamins and minerals, among others.
See Also
What is Mega Lifesciences PCL's Long-Term Debt?
Long-Term Debt
121.9m
THB
Based on the financial report for Sep 30, 2025, Mega Lifesciences PCL's Long-Term Debt amounts to 121.9m THB.
What is Mega Lifesciences PCL's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
1%
Over the last year, the Long-Term Debt growth was -16%. The average annual Long-Term Debt growth rates for Mega Lifesciences PCL have been 8% over the past three years , and 1% over the past ten years .
